Autoimmune hemolytic anemia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
 
(15 intermediate revisions by 5 users not shown)
Line 2: Line 2:
{{Autoimmune hemolytic anemia}}
{{Autoimmune hemolytic anemia}}


{{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]
{{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]; {{shyam}}, [[User:Irfan Dotani|Irfan Dotani]] [3]
 
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.


==Overview==
==Overview==
Overall, the [[incidence]] and [[prevalence]] of autoimmune hemolytic anemia are low. This condition affects a very small proportion of the population. Autoimmune hemolytic anemia affects men and women equally. There is no racial predilection for autoimmune hemolytic anemia.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
AIHA is a relatively rare condition, affecting one to three people per 100,000 per year <ref>{{cite journal |author=Böttiger LE, Westerholm B |title=Acquired haemolytic anaemia. I. Incidence and aetiology |journal=Acta Med Scand |volume=193 |issue=3 |pages=223–6 |year=1973 |month=March |pmid=4739592 }}</ref>.
 
=== Incidence ===
*The incidence of autoimmune hemolytic anemia overall is estimated to be between 0.8 in 100,000 and 3 in 100,000 per year.<ref>{{cite journal |author=Böttiger LE, Westerholm B |title=Acquired haemolytic anaemia. I. Incidence and aetiology |journal=Acta Med Scand |volume=193 |issue=3 |pages=223–6 |year=1973 |month=March |pmid=4739592 }}</ref><ref name="pmid26696798">{{cite journal| author=Berentsen S| title=Role of Complement in Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 303-10 | pmid=26696798 | doi=10.1159/000438964 | pmc=4678321 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696798  }} </ref><ref name="pmid25271314">{{cite journal| author=Zanella A, Barcellini W| title=Treatment of autoimmune hemolytic anemias. | journal=Haematologica | year= 2014 | volume= 99 | issue= 10 | pages= 1547-54 | pmid=25271314 | doi=10.3324/haematol.2014.114561 | pmc=4181250 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25271314  }} </ref>
*The incidence of [[warm autoimmune hemolytic anemia]] is estimated to be between 1.25 in 100,000 and 1.33 in 100,000.<ref name="pmid26696800">{{cite journal| author=Packman CH| title=The Clinical Pictures of Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 317-24 | pmid=26696800 | doi=10.1159/000440656 | pmc=4678314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696800  }} </ref>
*The incidence of [[Drug induced hemolytic anemia (patient information)|drug-induced hemolytic anemia]] is 1 in 1,000,000.<ref name="pmid26696800">{{cite journal| author=Packman CH| title=The Clinical Pictures of Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 317-24 | pmid=26696800 | doi=10.1159/000440656 | pmc=4678314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696800  }} </ref>
 
=== Prevalence ===
*The prevalence of autoimmune hemolytic anemia is 17 in 100,000.<ref name="pmid25271314">{{cite journal| author=Zanella A, Barcellini W| title=Treatment of autoimmune hemolytic anemias. | journal=Haematologica | year= 2014 | volume= 99 | issue= 10 | pages= 1547-54 | pmid=25271314 | doi=10.3324/haematol.2014.114561 | pmc=4181250 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25271314  }} </ref>
 
=== Age ===
* The incidence of autoimmune hemolytic anemia in children is 0.2 in 100,000.<ref name="pmid25271314" />
* The incidence of autoimmune hemolytic anemia is higher in adults that in children.<ref name="pmid26696798" />
 
=== Race ===
* Autoimmune hemolytic anemia affects all racial backgrounds equally.
 
=== Gender ===
*Autoimmune hemolytic anemia affects men and women equally.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{Hematology}}
[[Category:Hematology]]
[[Category:Hematology]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 11:56, 20 September 2018

Autoimmune hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune hemolytic anemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune hemolytic anemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune hemolytic anemia epidemiology and demographics

CDC on Autoimmune hemolytic anemia epidemiology and demographics

Autoimmune hemolytic anemia epidemiology and demographics in the news

Blogs on Autoimmune hemolytic anemia epidemiology and demographics

Directions to Hospitals Treating Autoimmune hemolytic anemia

Risk calculators and risk factors for Autoimmune hemolytic anemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S; Shyam Patel [2], Irfan Dotani [3]

Overview

Overall, the incidence and prevalence of autoimmune hemolytic anemia are low. This condition affects a very small proportion of the population. Autoimmune hemolytic anemia affects men and women equally. There is no racial predilection for autoimmune hemolytic anemia.

Epidemiology and Demographics

Incidence

Prevalence

  • The prevalence of autoimmune hemolytic anemia is 17 in 100,000.[3]

Age

  • The incidence of autoimmune hemolytic anemia in children is 0.2 in 100,000.[3]
  • The incidence of autoimmune hemolytic anemia is higher in adults that in children.[2]

Race

  • Autoimmune hemolytic anemia affects all racial backgrounds equally.

Gender

  • Autoimmune hemolytic anemia affects men and women equally.

References

  1. ↑ Böttiger LE, Westerholm B (1973). "Acquired haemolytic anaemia. I. Incidence and aetiology". Acta Med Scand. 193 (3): 223–6. PMID 4739592. Unknown parameter |month= ignored (help)
  2. ↑ 2.0 2.1 Berentsen S (2015). "Role of Complement in Autoimmune Hemolytic Anemia". Transfus Med Hemother. 42 (5): 303–10. doi:10.1159/000438964. PMC 4678321. PMID 26696798.
  3. ↑ 3.0 3.1 3.2 Zanella A, Barcellini W (2014). "Treatment of autoimmune hemolytic anemias". Haematologica. 99 (10): 1547–54. doi:10.3324/haematol.2014.114561. PMC 4181250. PMID 25271314.
  4. ↑ 4.0 4.1 Packman CH (2015). "The Clinical Pictures of Autoimmune Hemolytic Anemia". Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Autoimmune_hemolytic_anemia_epidemiology_and_demographics&oldid=1494905"